Cholinesterase Inhibitors
Links shared publicly online about this topic
No Benefit, Possible Harm With Cholinesterase Inhibitor for Delirium - QualityPoint Technologies
qualitypointtech.net — “A randomized trial of rivastigmine was halted early based on increased mortality and worse outcome in critically ill patients vs placebo. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on November 8, 2010 at 6:18 pm By:
No Benefit, Possible Harm With Cholinesterase Inhibitor for Delirium: A randomized trial of rivastigmine was halte... http://bit.ly/9Pd7rq
Overrated Medications Series: No. 4 Cholinesterase Inhibitors for Alzheimer’s Dementia « BITTERSWEET MEDICINE
bittersweetmedicine.com — “Overrated Medications Series: No. 4 Cholinesterase Inhibitors for Alzheimer’s Dementia « BITTERSWEET MEDICINE” View full resource at bittersweetmedicine.com
Most Recently Shared on November 9, 2011 at 9:01 pm By:
David Perlmutter Neurologist, Physician, and Doctor
How do we know Alzheimer's drugs are ineffective? : http://t.co/FQEvs2C7
Common #Alzheimers Medication Helps Skills Necessary for Safe #Driving http://ow.ly/1QULQ #cholinesterase inhibitors #ChEI
blogs.brown.edu — “Common #Alzheimers Medication Helps Skills Necessary for Safe #Driving http://ow.ly/1QULQ #cholinesterase inhibitors #ChEI” View full resource at blogs.brown.edu
Most Recently Shared on May 28, 2010 at 3:15 am By:
Health Literacy Medical School
Common #Alzheimers Medication Helps Skills Necessary for Safe #Driving http://ow.ly/1QULQ #cholinesterase inhibitors #ChEI
Medical News: Donepezil No Help for Memory Deficits in MS - in Clinical Context, Multiple Sclerosis from MedPage Today
medpagetoday.com — “The cholinesterase inhibitor donepezil (Aricept) failed to improve multiple sclerosis patients' memory impairments in a placebo-controlled trial, researchers said.” View full resource at medpagetoday.com
Most Recently Shared on April 30, 2011 at 2:22 am By:
Donepezil No Help for Memory Deficits in MS (CME/CE): (MedPage Today) -- The cholinesterase inhibitor donepezil ... http://bit.ly/iOzze3
Psychiatry Medical News about Schizophrenia
mdlinx.com — “Cholinesterase Inhibitors as Adjunctive Therapy in Patients with Schizophrenia and Schizoaffective Disorder: A Review and Meta-Analysis of the Literature” View full resource at mdlinx.com
Most Recently Shared on March 23, 2010 at 10:03 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cholinesterase Inhibitors as Adjunctive Therapy in Patients with Schizophrenia and Schizoaffective Disorder: A... http://bit.ly/aeGrKy #PSY
Neurology Medical News about Alzheimer Disease
mdlinx.com — “Predictive Factors of Discontinuation and Switch of Cholinesterase Inhibitors in Community-Dwelling Patients with Alzheimer's Disease: A 2-Year Prospective, Multicentre, Cohort Study” View full resource at mdlinx.com
Most Recently Shared on April 15, 2010 at 9:29 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Predictive Factors of Discontinuation and Switch of Cholinesterase Inhibitors in Community-Dwell... http://bit.ly/cAOgAX #neurology #mdlinx
Risk Among Dementia Drugs | Psych Central News
psychcentral.com — “A new Canadian study suggests the side effects associated with several commonly prescribed dementia medications may be putting individuals at risk.” View full resource at psychcentral.com
Most Recently Shared on May 28, 2009 at 2:29 pm By:
Psychology Headline: Risk Among Dementia Drugs @http://is.gd/Ibjh
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial : The Lancet
thelancet.com — “Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised tria...” View full resource at thelancet.com
Most Recently Shared on November 5, 2010 at 7:52 am By:
We have published a study showing Rivastigmine does not decrease delirium and might increase mortality in critical care http://bit.ly/9oD61a
Liquid formulations: A practical alternative — Current Psychiatry Online
currentpsychiatry.com — “Liquid formulations: A practical alternative — Current Psychiatry Online” View full resource at currentpsychiatry.com
Most Recently Shared on November 30, 2010 at 1:00 pm By:
Current Psychiatry Psychiatry and Medical Journal
Liquid formulations of psychotropics are especially helpful for uncooperative or agitated patients http://bit.ly/e88bHl
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial : The Lancet
thelancet.com — “Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised tria...” View full resource at thelancet.com
Most Recently Shared on November 10, 2010 at 7:29 pm By:
PalMD Doctor, Internist, and Physician
Study of Exelon in hosp. delirium stopped due to excess mortality http://bit.ly/adSLBf http://www.thelancet.com/
Forest And Merz Announce FDA Approval Of Namenda XR For The Treatment Of Moderate To Severe Dementia Of The Alzheimer's Type
medicalnewstoday.com — “Forest Laboratories, Inc. (NYSE: FRX) and Merz Pharmaceuticals GmbH announced that Namenda XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment” View full resource at medicalnewstoday.com
Most Recently Shared on June 23, 2010 at 1:05 pm By:
MNT Alzheimer's News Health News
Forest And Merz Announce FDA Approval Of Namenda XR For The Treatment Of Moderate To Severe Dementia Of The Alzheimer'... http://mnt.to/3Fdh
Medical News: Donepezil No Help for Memory Deficits in MS - in Clinical Context, Multiple Sclerosis from MedPage Today
medpagetoday.com — “The cholinesterase inhibitor donepezil (Aricept) failed to improve multiple sclerosis patients' memory impairments in a placebo-controlled trial, researchers said.” View full resource at medpagetoday.com
Most Recently Shared on May 2, 2011 at 10:52 am By:
Dr. Brian Goldman Doctor, Emergency Physician, and Physician
Donepezil No Help for Memory Deficits in MS http://t.co/8Oyr756 A drug in search of an indication.
Infectious Disease News & Articles - MDLinx - Pneumonia on #MDlinx
mdlinx.com — “Infectious Disease News & Articles - MDLinx - Pneumonia on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on July 31, 2010 at 1:26 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Early onset pneumonia in patients with cholinesterase inhibitor poisoning: Respirology http://bit.ly/cFINkO #ID
Medical News: ICAD: Alzheimer's Drugs Fail to Deliver Survival Benefit - in Meeting Coverage, ICAD from MedPage Today
medpagetoday.com — “PARIS -- A new, more detailed analysis has essentially erased the survival benefit for dementia patients treated with cholinesterase inhibitor drugs, according to the researcher who reported the initi” View full resource at medpagetoday.com
Most Recently Shared on July 20, 2011 at 12:55 am By:
ICAD: Alzheimer's Drugs Fail to Deliver Survival Benefit (CME/CE): PARIS (MedPage Today) -- A… http://goo.gl/fb/C1x4E
A phase II trial of huperzine A in mild to moderat... [Neurology. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on May 24, 2011 at 5:23 pm By:
Jennie Byrne MD PhD Psychiatrist, Physician, PhD, and Doctor
Huperzine A - a "natural" cholinesterase inhibitor may help in mild-moderate Alzheimer's with fewer side effects http://tinyurl.com/3zzcgvk
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
David Perlmutter
-
Health Literacy
Information on Health Literacy and Public Health
Advertisement
